Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy

Journal of Microencapsulation

Volumn 13, Issue 3, 1996, Pages 269-279

  Mehta, S C ^a   Lai, J C K ^b   Lu, D R ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b IDAHO STATE UNIVERSITY   (United States)

Author keywords

BNCT; Boron neutron capture therapy; BSH; Liposomes; Mice; Polyethylene glycol; Sodium mercaptoundecahydrododecaborate

Indexed keywords

BOROCAPTATE; BORON DERIVATIVE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; LIVER LEVEL; MALE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; SPLEEN;

EID: 0029874728     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049609026015     Document Type: Article

References (31)

1. ABUIZZAH, K., and LU, D. R., High performance liquid Chromatographic determination of sodium mercaptoundecahydrododecaborate with precolumn derivatization. Journal of Chromatography, Biomedical Applications, 660(2), 347-352.
2. ALAM, F., BAPAT, B. V., SOLOWAY, A. M., BARTH, R. F., MAFUNE, N., and ADAMS, D. M., 1989a, Boronated compounds for neutron capture therapy. Strahlentherapie und Onkologie, 165, 121-123.
3. ALAM, F., SOLOWAY, A. H., BARTH, R. F., MAFUNE, N., ADAMS, D. M., and KNOTH, W. H., 1989b, Boron neutron capture therapy: linkage of a boronated macromolecule to monoclonal antibodies directed against tumor associated antigens. Journal of Medical Chemistry, 32, 2326-2330.
4. ALLEN, T. M., MEHRA, T., HANSEN, C., and CHIN, Y. C., 1992, Stealth liposomes: An improved sustained release system for 1-β-D-arabinofuranosylcytosine. Cancer Research, 52, 2431-2439.
5. BARTH, R. F., SOLOWAY, A. H., and FAIRCHILD, R. G., 1990, Boron neutron capture therapy for cancer. Cancer Research, 50, 1061-1070.
6. GABIZON, A., PRICE, D. C., HUBERTY, J., BRESALIER, R. S., and PAPAHADJOPOULOS, D., 1990, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Research, 50, 6371-6378.
7. GREGOIRE, V., BEGG, A. C., HUISKAMP, R., VERRIJK, R., and BARTELINK, H., 1993, Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors. Radiotherapy and Oncology, 27, 46-54.
8. GREGORIADIS, G., 1991, Overview of liposomes. Journal of Antimicrobial Chemotherapy, 28(Suppl. B), 39-54.
9. GREGORLADIS, G., and FLORENCE, A. T., 1991, Liposomes and cancer therapy. Cancer Cells, 2(4), 144-146.
10. GREGORIADIS, G., and FLORENCE, A. T., 1993, Liposomes in drug delivery: Clinical, diagnostic and ophthalmic potential. Drugs, 45(1), 15-28.
11. HARASHIMA, H., SAWADA, Y., SUGIYAMA, H., IGA, T., and HANANO, M., 1985, Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 13, 425-440.
12. 10B-paraboronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vivo radiological evaluation. Journal of Investigative Dermatology, 78, 215-218.
13. KAHL, S. B., JOEL, D. D., NAWROCKY, M. M., MICCA, P. L., TRAN, K. P., and FINKEL, G. C., 1990, Uptake of a nido-carboranylporphyrine by human glioma xenografts in athymic nude mice and by synergistic ovarian carcinomas in immnunocompetent mice. Proceedings of the National Academy of Science, USA, 87, 7265-7269.
14. LAHANN, T. R., LU, D. R., DANIELL, G., SILLS, C., KRAFT, S. L., GAVIN, P. R., and BAUER, W. F., 1993, Bioavailability of intravenous formulations of p-Boronophenylalanine in dog and rat. Advances in Neutron Capture Therapy, edited by R. F. Barth and A. H. Soloway (Plenum Press, New York), pp. 585-589.
15. LAHANN, T., BAUER, W. F., and LU, D. R., 1994, Pharmacokinetics of boronophenylalanine delivered in HP-β-cyclodextrin formulation. Polymeric Drugs and Drug Delivery Systems, edited by R. M. Ottenbrite (ACS Book Series 545, American Chemical Society, Washington, DC), pp. 66-78.
16. MARUYAMA, K., YUDA, T., OKAMOTO, A., KOJIMA, S., SUGINAKA, A., and IWATSURU, M., 1992, Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochimica et Biophysica Acta, 1128, 44-49.
17. MEHTA, S. C., BOUDINOT, F. D., and LU, D. R., 1995, Pharmacokinetics of sodium mercaptoundecahydrododecaborate (BSH) after intravenous injection in rats. Drug Metabolism and Disposition (In press).
18. 10B-chlorpromazine compound. Pigment Cell, edited by V. Riley (Karger, Basel), pp. 215-221.
19. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Letters, 284(2), 263-266.
20. PAPAHADJOPOULOS, D., and GABIZON, A., 1987, Targeting of liposomes to tumor cells in vivo. Annals of the New York Academy of Science, 507, 64-74.
21. PAPAHADJOPOULOS, D., ALLEN, T. M., GABIZON, A., MAYHEW, E., MATTHAY, K., HUANG, S. K., LEE, K. D., WOODLE, M. C., LASIC, D. D., REDEMANN, C., and MARTIN, F. J., 1991, Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proceedings of the National Academy of Science, USA, 88, 11460-11464.
22. SAINI, P., ABUIZZAH, K., and LU, D. R., 1995, High performance liquid Chromatographic assay for sodium mercaptoundecahydrododecaborate in rat tissues. Journal of Chromatography, Biomedical Applications, 665, 155-161.
23. SCHINAZI, R. F., and PRUSOFF, W. H., 1978, Synthesis and properties of boron and silicon substituted uracil or 2-deoxyuridine. Tetrahedron Letters, 50, 4981-4984.
24. SHELLY, E., FEAKS, D. A., HAWTHORNE, M. F., SCHMIDT, P. G., KRISCH, T. A., and BAUER, W. F., 1992, Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proceedings of the National Academy of Science, USA, 89, 9039-9043.
25. SOLOWAY, A. H., HATANAKA, H., and DAVIS, M. A., 1967, Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. Journal of Medical Chemistry, 10, 714-717.
26. SPIELVOGEL, B. F., GOOD, A., HALL, I. H., FAIRCHILD, R. G., and MICCA, P. L., 1989, Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds. Strahlentherepie und Onkologie, 165, 123-125.
27. TJARKS, W., and GABEL, D., 1991, Boron-containing thiouracil derivatives for neutron-capture therapy of melanoma. Journal of Medical Chemistry, 34, 315-319.
28. VARADARAJAN, A., SHARKEY, R. M., GOLDENBERG, D. M., and HAWTHORNE, M. D., 1991, Conjugation of phenyl isothiocyanate derivatives of carborate to antitumor antibody and in-vivo localization of conjugates in nude mice. Bioconjugate Chemistry, 2., 102-110.
29. WOODLE, M. C., and LASIC, D. D., 1992, Sterically stabilized liposomes. Biochimica et Biophysica Acta, 1113, 171-199.
30. WU, N. Z., DA, D., RUDOLL, T. L., NEEDHAM, D., WHORTON, A. P., and DEWTHIRST, M. W., 1993, Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Research, 53, 3765-3770.
31. YANAGIE, H., TOMITA, T., KOBAYASHI, H., FUJI, F., TAKAHASHI, T., HASUMI, K., NARIUCHI, H., and SEKIGUCHI, M., 1991, Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in vitro boron neutron capture therapy model. British Journal of Cancer, 63, 522-526.